ArticlePharmaceuticals (Basel, Switzerland)2024

Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia.

Mariarita Spampinato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.